PureTech Health Archives -

Roche’s idiopathic pulmonary fibrosis (IPF) therapy Esbriet is already being squeezed by its main rival in the market,

PureTech challenges Roche’s Esbriet in head-to-head IPF trial

https://pharmaphorum.com/news/puretech-challenges-roches-esbriet-in-head-to-head-ipf-trial/

In latest episode of our Health Innovators video interview series, Dr Paul Tunnah speaks to Daphne Zohar, the

Health Innovators: PureTech Health’s Daphne Zohar

https://pharmaphorum.com/r-d/health-innovators-daphne-zohar-puretech/

Akili has published data backing the efficacy of its childhood attention-deficit hyperactivity disorder (ADHD) video game therapy EndeavorRx

Akili’s gaming therapy improves attention in ADHD kids

https://pharmaphorum.com/news/akilis-gaming-therapy-improves-attention-in-adhd-kids/

An app to treat children with attention-deficit hyperactivity disorder (ADHD) developed by Akili has been made available ahead

COVID-19 gives Akili’s digital ADHD treatment an early debut in US

https://pharmaphorum.com/news/covid-19-gives-akilis-digital-adhd-treatment-an-early-debut-in-us/

Karuna Therapeutics has raised $68 million to further develop its neurology drug KarXT, which is in phase 2

Karuna raises $68m to develop neurology drug KarXT

https://pharmaphorum.com/news/karuna-raises-68m-to-develop-neurology-drug-karxt/

US biotech PureTech Health is to develop therapies that are based on a new theory that neurological diseases

PureTech to research Alzheimer’s drugs based on ‘brain drain’ theory

https://pharmaphorum.com/news/puretech-research-alzheimers-brain-drain-theory/

PureTech Health